“Rethinking Phase 2 Trials in ALS”

Publication highlighting the lessons learned from a rich history of ALS clinical trials, with the goal of optimizing the design and implementation of future phase 2 trials to maximize the likelihood of developing meaningfully effective treatments for ALS.